Bengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on ...

Clinical trials have demonstrated that both biosimilars match the reference product's quality, safety and efficacy standards.

CA Rudramurthy BV is bullish on Biocon and DMart, citing strong technical setups and sectoral promise. Biocon’s breakout from ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

Biocon founder Kiran Mazumdar Shaw and Karnataka Chief Minister Siddaramaiah debated on X over the safety of Covid-19 ...

Biocon chief Kiran Mazumdar-Shaw has pushed back against Karnataka Chief Minister Siddaramaiah's recent claim that COVID-19 ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Biocon founder Kiran Mazumdar-Shaw refutes Karnataka CM's claim linking Covid-19 vaccines to heart attack deaths in Hassan ...

Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

Yesafili is a VEGF inhibitor indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), ...